Literature DB >> 29884332

Common variants in the CLDN2-MORC4 and PRSS1-PRSS2 loci confer susceptibility to acute pancreatitis.

Frank Ulrich Weiss1, Nico Hesselbarth2, Andrea Párniczky3, Dora Mosztbacher4, Felix Lämmerhirt1, Claudia Ruffert2, Peter Kovacs5, Sebastian Beer6, Katharina Seltsam6, Heidi Griesmann2, Richard Böhme2, Tom Kaune2, Marcus Hollenbach6, Hans-Ulrich Schulz7, Peter Simon1, Julia Mayerle8, Markus M Lerch1, Giulia Martina Cavestro9, Raffaella Alessia Zuppardo9, Milena Di Leo9, Pier Alberto Testoni9, Ewa Malecka-Panas10, Anita Gasirowska10, Stanislaw Głuszek11, Peter Bugert12, Andrea Szentesi13, Joachim Mössner6, Heiko Witt14, Patrick Michl2, Peter Hégyi15, Markus Scholz16, Jonas Rosendahl17.   

Abstract

BACKGROUND/
OBJECTIVES: Acute pancreatitis (AP) is one of the most common gastrointestinal disorders often requiring hospitalization. Frequent aetiologies are gallstones and alcohol abuse. In contrast to chronic pancreatitis (CP) few robust genetic associations have been described. Here we analysed whether common variants in the CLDN2-MORC4 and the PRSS1-PRSS2 locus that increase recurrent AP and CP risk associate with AP.
METHODS: We screened 1462 AP patients and 3999 controls with melting curve analysis for SNPs rs10273639 (PRSS1-PRSS2), rs7057398 (RIPPLY), and rs12688220 (MORC4). Calculations were performed for the overall group, aetiology, and gender sub-groups. To examine genotype-phenotype relationships we performed several meta-analyses.
RESULTS: Meta-analyses of all AP patients depicted significant (p-value < 0.05) associations for rs10273639 (odds ratio (OR) 0.88, 95% confidence interval (CI) 0.81-0.97, p-value 0.01), rs7057398 (OR 1.27, 95% CI 1.07-1.5, p-value 0.005), and rs12688220 (OR 1.32, 95% CI 1.12-1.56, p-value 0.001). For the different aetiology groups a significant association was shown for rs10273639 (OR 0.76, 95% CI 0.63-0.92, p-value 0.005), rs7057398 (OR 1.43, 95% CI 1.07-1.92, p-value 0.02), and rs12688220 (OR 1.44, 95% CI 1.07-1.93, p-value 0.02) in the alcoholic sub-group only.
CONCLUSIONS: The association of CP risk variants with different AP aetiologies, which is strongest in the alcoholic AP group, might implicate common pathomechanisms most likely between alcoholic AP and CP.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Acute pancreatitis; Genetics; Risk factors; Single nucleotide polymorphisms

Year:  2018        PMID: 29884332     DOI: 10.1016/j.pan.2018.05.486

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  6 in total

Review 1.  Etiology and Risk Factors of Acute and Chronic Pancreatitis.

Authors:  Frank Ulrich Weiss; Felix Laemmerhirt; Markus M Lerch
Journal:  Visc Med       Date:  2019-03-13

2.  The Polymorphisms at PRSS1-PRSS2 and MORC4 Loci and the Risk of Post-ERCP Pancreatitis.

Authors:  Phonthep Angsuwatcharakon; Pimpayao Sodsai; Rungsun Rerknimitr; Nattiya Hirankarn
Journal:  Gastroenterol Res Pract       Date:  2018-11-04       Impact factor: 2.260

3.  Response to Liu et al.

Authors:  Mark O Goodarzi; David C Whitcomb
Journal:  Clin Transl Gastroenterol       Date:  2019-11       Impact factor: 4.488

4.  An intersectional analysis of LncRNAs and mRNAs reveals the potential therapeutic targets of Bi Zhong Xiao Decoction in collagen-induced arthritis rats.

Authors:  Cailin He; Yang Wang; Yuqi Wen; Teng Li; En Hu; Siqing Zeng; Bo Yang; Xingui Xiong
Journal:  Chin Med       Date:  2022-09-16       Impact factor: 4.546

5.  Role of the Common PRSS1-PRSS2 Haplotype in Alcoholic and Non-Alcoholic Chronic Pancreatitis: Meta- and Re-Analyses.

Authors:  Anthony F Herzig; Emmanuelle Génin; David N Cooper; Emmanuelle Masson; Claude Férec; Jian-Min Chen
Journal:  Genes (Basel)       Date:  2020-11-13       Impact factor: 4.096

6.  Molecular mechanism of the MORC4 ATPase activation.

Authors:  Adam H Tencer; Khan L Cox; Gregory M Wright; Yi Zhang; Christopher J Petell; Brianna J Klein; Brian D Strahl; Joshua C Black; Michael G Poirier; Tatiana G Kutateladze
Journal:  Nat Commun       Date:  2020-10-29       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.